Zoetis (NYSE:ZTS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Zoetis (ZTS) operate in?

Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.

Open	$192.94
Close	$192.64
Volume / Avg.	3.52M / 2.03M
Day Range	$191.07 - $194.55
52 Wk Range	144.80 - 201.92
Market Cap	$87.28B
P/E Ratio	37.89
Dividend Yield	0.89%
Exchange	NYSE
RSI	61
Short Interest	1.12%
Days to Cover	3.58

Recent News

Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to vaccination warnings and adverse event concerns.

Vandana Singh

Corcept Moves 6.5% Higher: Will This Strength Last?

Corcept Therapeutics (NASDAQ: CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.7% gain over the past four weeks.

Zacks

Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Zoetis Inc

Sector

Health Care

Industry

Pharmaceuticals

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for an...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Zoetis (ZTS) stock?

You can purchase shares of Zoetis (NYSE:ZTS) through any online brokerage.

View our list of the best stock brokerages

Who are Zoetis (ZTS) competitors?

Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the forecast, or price target, for Zoetis (ZTS) stock?

There is no analysis for Zoetis to provide a consensus price target.

What is the current price for Zoetis (ZTS)?

The stock price for Zoetis (NYSE: ZTS) is $192.64 last updated September 20, 2024 at 4:39 PM EDT.

Does Zoetis (ZTS) pay a dividend?

A quarterly cash dividend of 0.43 per share of Class A Common Stock. The quarterly cash dividend was payable on September 4, 2024 to stockholders of record on July 18, 2024.

When is Zoetis (NYSE:ZTS) reporting earnings?

Zoetis does not have any upcoming earnings scheduled.

Is Zoetis (ZTS) going to split?

There is no upcoming split for Zoetis.

What sector and industry does Zoetis (ZTS) operate in?

Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now